Contact system activation in human sepsis - 47kD HK, a marker of sepsis severity?

Lars M. Asmis, Reto Asmis, Irmela Sulzer, Miha Furlan, Bernhard Lämmle

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Aim: This pilot study seeks to determine whether contact system activation (CSA) occurs in human sepsis patients and to characterise blood levels of the 47kD light chain of high-molecular weight kininogen (47kD HK). Methods: Six consecutive patients with clinical suspicion of sepsis were evaluated on days 1, 2, 3 and 6-8 for 47kD HK blood levels expressed in U/ml of whole blood and as percent of total HK. 47kD HK was measured in whole blood by quantitative immunoblot analysis. Results: On study day 1 or 2, analysis of 47kD HK in U/ml of whole blood identified CSA in 3/6 patients. When 47kD HK levels were expressed as percent of total HK, 4/6 patients were identified with CSA before day 3. The degree of CSA as assayed by the presence of 47kD HK correlated with the severity of the systemic inflammatory syndrome (SIRS), i.e. mean CSA increased progressively from basal levels in healthy controls (0.08 U/ml or 10.4%) to patients without SIRS (0.10 U/ml or 15.1%), to patients with sepsis (0.12 U/ml or 15.0%), and finally to patients in a combined category of severe sepsis and septic shock (0.13 U/ml or 17.4%). Conclusion: CSA, defined by increased 47kD HK, occurred early on in the course of sepsis in a subset of sepsis patients. 47kD HK levels, an indicator of bradykinin release, correlated with sepsis severity. Future larger studies will need to evaluate the role of 47kD HK as a biomarker for both prognosis and treatment response in human sepsis.

Original languageEnglish (US)
Pages (from-to)142-149
Number of pages8
JournalSwiss Medical Weekly
Volume138
Issue number9-10
StatePublished - Mar 8 2008
Externally publishedYes

Fingerprint

Sepsis
High Molecular Weight Kininogens
Bradykinin
Septic Shock
Biomarkers
Light

Keywords

  • Bradykinin
  • Contact system activation
  • High-molecular weight kininogen
  • Sepsis
  • Systemic inflammatory response syndrome

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Asmis, L. M., Asmis, R., Sulzer, I., Furlan, M., & Lämmle, B. (2008). Contact system activation in human sepsis - 47kD HK, a marker of sepsis severity? Swiss Medical Weekly, 138(9-10), 142-149.

Contact system activation in human sepsis - 47kD HK, a marker of sepsis severity? / Asmis, Lars M.; Asmis, Reto; Sulzer, Irmela; Furlan, Miha; Lämmle, Bernhard.

In: Swiss Medical Weekly, Vol. 138, No. 9-10, 08.03.2008, p. 142-149.

Research output: Contribution to journalArticle

Asmis, LM, Asmis, R, Sulzer, I, Furlan, M & Lämmle, B 2008, 'Contact system activation in human sepsis - 47kD HK, a marker of sepsis severity?', Swiss Medical Weekly, vol. 138, no. 9-10, pp. 142-149.
Asmis LM, Asmis R, Sulzer I, Furlan M, Lämmle B. Contact system activation in human sepsis - 47kD HK, a marker of sepsis severity? Swiss Medical Weekly. 2008 Mar 8;138(9-10):142-149.
Asmis, Lars M. ; Asmis, Reto ; Sulzer, Irmela ; Furlan, Miha ; Lämmle, Bernhard. / Contact system activation in human sepsis - 47kD HK, a marker of sepsis severity?. In: Swiss Medical Weekly. 2008 ; Vol. 138, No. 9-10. pp. 142-149.
@article{d78e8b92e9054b609536fc8a62bd0697,
title = "Contact system activation in human sepsis - 47kD HK, a marker of sepsis severity?",
abstract = "Aim: This pilot study seeks to determine whether contact system activation (CSA) occurs in human sepsis patients and to characterise blood levels of the 47kD light chain of high-molecular weight kininogen (47kD HK). Methods: Six consecutive patients with clinical suspicion of sepsis were evaluated on days 1, 2, 3 and 6-8 for 47kD HK blood levels expressed in U/ml of whole blood and as percent of total HK. 47kD HK was measured in whole blood by quantitative immunoblot analysis. Results: On study day 1 or 2, analysis of 47kD HK in U/ml of whole blood identified CSA in 3/6 patients. When 47kD HK levels were expressed as percent of total HK, 4/6 patients were identified with CSA before day 3. The degree of CSA as assayed by the presence of 47kD HK correlated with the severity of the systemic inflammatory syndrome (SIRS), i.e. mean CSA increased progressively from basal levels in healthy controls (0.08 U/ml or 10.4{\%}) to patients without SIRS (0.10 U/ml or 15.1{\%}), to patients with sepsis (0.12 U/ml or 15.0{\%}), and finally to patients in a combined category of severe sepsis and septic shock (0.13 U/ml or 17.4{\%}). Conclusion: CSA, defined by increased 47kD HK, occurred early on in the course of sepsis in a subset of sepsis patients. 47kD HK levels, an indicator of bradykinin release, correlated with sepsis severity. Future larger studies will need to evaluate the role of 47kD HK as a biomarker for both prognosis and treatment response in human sepsis.",
keywords = "Bradykinin, Contact system activation, High-molecular weight kininogen, Sepsis, Systemic inflammatory response syndrome",
author = "Asmis, {Lars M.} and Reto Asmis and Irmela Sulzer and Miha Furlan and Bernhard L{\"a}mmle",
year = "2008",
month = "3",
day = "8",
language = "English (US)",
volume = "138",
pages = "142--149",
journal = "Swiss Medical Weekly",
issn = "1424-7860",
publisher = "EMH Swiss Medical Publishers Ltd.",
number = "9-10",

}

TY - JOUR

T1 - Contact system activation in human sepsis - 47kD HK, a marker of sepsis severity?

AU - Asmis, Lars M.

AU - Asmis, Reto

AU - Sulzer, Irmela

AU - Furlan, Miha

AU - Lämmle, Bernhard

PY - 2008/3/8

Y1 - 2008/3/8

N2 - Aim: This pilot study seeks to determine whether contact system activation (CSA) occurs in human sepsis patients and to characterise blood levels of the 47kD light chain of high-molecular weight kininogen (47kD HK). Methods: Six consecutive patients with clinical suspicion of sepsis were evaluated on days 1, 2, 3 and 6-8 for 47kD HK blood levels expressed in U/ml of whole blood and as percent of total HK. 47kD HK was measured in whole blood by quantitative immunoblot analysis. Results: On study day 1 or 2, analysis of 47kD HK in U/ml of whole blood identified CSA in 3/6 patients. When 47kD HK levels were expressed as percent of total HK, 4/6 patients were identified with CSA before day 3. The degree of CSA as assayed by the presence of 47kD HK correlated with the severity of the systemic inflammatory syndrome (SIRS), i.e. mean CSA increased progressively from basal levels in healthy controls (0.08 U/ml or 10.4%) to patients without SIRS (0.10 U/ml or 15.1%), to patients with sepsis (0.12 U/ml or 15.0%), and finally to patients in a combined category of severe sepsis and septic shock (0.13 U/ml or 17.4%). Conclusion: CSA, defined by increased 47kD HK, occurred early on in the course of sepsis in a subset of sepsis patients. 47kD HK levels, an indicator of bradykinin release, correlated with sepsis severity. Future larger studies will need to evaluate the role of 47kD HK as a biomarker for both prognosis and treatment response in human sepsis.

AB - Aim: This pilot study seeks to determine whether contact system activation (CSA) occurs in human sepsis patients and to characterise blood levels of the 47kD light chain of high-molecular weight kininogen (47kD HK). Methods: Six consecutive patients with clinical suspicion of sepsis were evaluated on days 1, 2, 3 and 6-8 for 47kD HK blood levels expressed in U/ml of whole blood and as percent of total HK. 47kD HK was measured in whole blood by quantitative immunoblot analysis. Results: On study day 1 or 2, analysis of 47kD HK in U/ml of whole blood identified CSA in 3/6 patients. When 47kD HK levels were expressed as percent of total HK, 4/6 patients were identified with CSA before day 3. The degree of CSA as assayed by the presence of 47kD HK correlated with the severity of the systemic inflammatory syndrome (SIRS), i.e. mean CSA increased progressively from basal levels in healthy controls (0.08 U/ml or 10.4%) to patients without SIRS (0.10 U/ml or 15.1%), to patients with sepsis (0.12 U/ml or 15.0%), and finally to patients in a combined category of severe sepsis and septic shock (0.13 U/ml or 17.4%). Conclusion: CSA, defined by increased 47kD HK, occurred early on in the course of sepsis in a subset of sepsis patients. 47kD HK levels, an indicator of bradykinin release, correlated with sepsis severity. Future larger studies will need to evaluate the role of 47kD HK as a biomarker for both prognosis and treatment response in human sepsis.

KW - Bradykinin

KW - Contact system activation

KW - High-molecular weight kininogen

KW - Sepsis

KW - Systemic inflammatory response syndrome

UR - http://www.scopus.com/inward/record.url?scp=40649107855&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40649107855&partnerID=8YFLogxK

M3 - Article

C2 - 18330734

AN - SCOPUS:40649107855

VL - 138

SP - 142

EP - 149

JO - Swiss Medical Weekly

JF - Swiss Medical Weekly

SN - 1424-7860

IS - 9-10

ER -